you are right Drano B-OM is inexpensive to delive
Post# of 72440
B-OM is inexpensive to deliver but costs of large multinational , mulitcenter phase 3 trials are fairly costly with its administrative and multiple "hidden " costs.
I may exacerbate with the range 50-100 mil but 25-50 mil is still needed for company to complete the study which mean we can't move on without the BP deal or take- over which I guess is less likely.
I am still behind my comment that BP is waiting for final EMA comments/approval .
I respect your opinion though
Aragon